Univest
Univest
  • Markets

Indraprastha Medical Corporation Ltd. (INDRAMEDCO) 52 Week Low Streak: Extended Breakdown Continues

  • October 6, 2026
  • Posted by: Kunal Singla
  • Category: News
No Comments
Indraprastha Medical Corporation Ltd. 52 Week Low Streak
Indraprastha Medical Corporation Ltd. (INDRAMEDCO) share price fell to a fresh 52-week low of Rs 327.45 today and later stood at Rs 329.05, down 1.51% from the previous close. Market cap was Rs 3,062.79 crore.

Indraprastha Medical Corporation Ltd. has now set a fresh 52-week low for its second straight session, extending a cumulative decline of 2.86% across the streak. The latest trough stands at Rs 327.45, while the current price is Rs 329.05. Univest data confirms the repeated-low pattern, but it does not establish a company-specific cause for the continued decline.

With a market capitalisation of Rs 3,062.79 crore, this repeated-low pattern matters more than a single-day break below the yearly floor. The Indraprastha Medical Corporation Ltd. 52 Week Low Streak signals that the stock has remained under pressure across consecutive sessions, so readers should track the next close, the cumulative move across the streak and whether the stock can stabilise above the latest trough.

Table of Contents

Toggle
  • Indraprastha Medical Corporation Ltd. 52 Week Low Streak: Consecutive Low Analysis
  • What the Repeated 52-Week Lows Show
  • Indraprastha Medical Corporation Ltd. (INDRAMEDCO) Fundamental Analysis
  • Sector and Industry Context
  • Peer Comparison
  • Why Investors Are Watching
  • About the Company
  • Track Indraprastha Medical Corporation Ltd. Share Price on Univest
  • Frequently Asked Questions
    • What does the Indraprastha Medical Corporation Ltd. 52 Week Low Streak mean?
    • How many sessions has the stock been making fresh 52-week lows?
    • What is the latest 52-week low for the stock?
    • Is a company-specific reason confirmed for the repeated lows?
    • How does the stock compare with the sector median on valuation?
    • What profitability metrics stand out in the data?
    • How should investors read the repeated low pattern?
    • What should investors track next?

Indraprastha Medical Corporation Ltd. 52 Week Low Streak: Consecutive Low Analysis

Metric Value
Current Price Rs 329.05
Previous Close Rs 334.1
Today's Move Rs -5.05 (-1.51%)
Open Rs 331.7
High Rs 334.5
Low Rs 327.45
Market Capitalisation Rs 3,062.79 crore

Indraprastha Medical Corporation Ltd. (INDRAMEDCO) traded at Rs 329.05 versus the previous close of Rs 334.1, a fall of 1.51%. The stock opened at Rs 331.7, reached a high of Rs 334.5, touched a low of Rs 327.45.

Indraprastha Medical Corporation Ltd. finished at Rs 329.05, compared with the previous close of Rs 334.10, which means the stock declined by Rs 5.05 or 1.51% in the latest session. The day opened at Rs 331.70, touched an intraday high of Rs 334.50 and a low of Rs 327.45, and closed close to the lower end of that range. The stock’s latest close also matched the fresh 52-week low, reinforcing the Indraprastha Medical Corporation Ltd. 52 Week Low Streak rather than interrupting it.

The session range was narrow enough to keep attention on the closing level, because the finish sat well below the opening print and beneath the previous close. Market capitalisation stood at Rs 3,062.79 crore, which places the stock in the current market context without changing the fact that the Indraprastha Medical Corporation Ltd. 52 Week Low Streak is being defined by repeated yearly lows, not by one isolated session. The cumulative decline of 2.86% across the streak is the more important read for this article than the one-day move alone.

What the Repeated 52-Week Lows Show

The Indraprastha Medical Corporation Ltd. 52 Week Low Streak tells readers that the stock has not merely slipped once; it has continued to print a new one-year low on each of the last two sessions. That pattern is important because it shows continuity in weakness across sessions, even though the latest Univest data does not identify a company-specific trigger. In other words, the streak itself is the signal.

For a reader tracking the Indraprastha Medical Corporation Ltd. 52 Week Low Streak, the key numbers are simple. The stock has fallen 2.86% across the streak and is now sitting at Rs 327.45 as the latest 52-week low. The previous session established the first break, and the latest session confirmed that the decline has not yet been reversed. This is why a streak-based read is more useful than a one-day headline.

Another way to view the Indraprastha Medical Corporation Ltd. 52 Week Low Streak is that the stock has remained unable to reclaim the prior session’s floor. That keeps the focus on whether the next session merely matches the low again or finally closes above it. Until that happens, the streak remains the dominant market fact.

Indraprastha Medical Corporation Ltd. (INDRAMEDCO) Fundamental Analysis

Metric Value
Market Capitalisation Rs 3,062.79 crore
P/E Ratio 16.29x
P/B Ratio 3.85x
ROE 27.47%
ROCE 37.7%
EPS Rs 20.51
Book Value Per Share Rs 86.85
Dividend Yield 1.2%

Indraprastha Medical Corporation Ltd. (INDRAMEDCO) fundamental metrics show P/E 16.29x, P/B 3.85x, ROE 27.47%, ROCE 37.7%. Taken on their own, these numbers offer context rather than a trading signal.

Indraprastha Medical Corporation Ltd. has a market capitalisation of Rs 3,062.79 crore, which gives readers a sense of company size before judging valuation. On valuation, P/E at 16.29x, P/B at 3.85x should be read against the sector and peer benchmarks rather than as a standalone signal. Profitability is represented by ROE of 27.47% and ROCE of 37.7%, helping investors compare shareholder returns and capital efficiency. According to latest Univest data, additional metrics include EPS of Rs 20.51, book value per share of Rs 86.85, dividend yield of 1.2%, adding context to earnings, balance-sheet value and historical payout. Against the latest Univest same industry benchmark, these figures can be compared with benchmark median P/E of 45.1x, median ROE of 12.95%, median ROCE of 15.83%. They set out the fundamental picture and are not a rating on the stock.

Sector and Industry Context

Metric Value
Sector Healthcare
Industry Hospital & Healthcare Services
Benchmark Scope same industry
Company P/E Ratio 16.29x
Benchmark Median P/E 45.1x
Benchmark Average P/E 98.5x
Benchmark P/E Range 6.78x to 1,588.84x
Company P/B Ratio 3.85x
Benchmark Median P/B 4.1x
Company ROE 27.47%
Benchmark Median ROE 12.95%
Company ROCE 37.7%
Benchmark Median ROCE 15.83%
Company Market Capitalisation Rs 3,062.79 crore
Benchmark Median Market Cap Rs 514.78 crore

Indraprastha Medical Corporation Ltd. (INDRAMEDCO) operates in the Healthcare sector, within the Hospital & Healthcare Services industry.

Indraprastha Medical Corporation Ltd. (INDRAMEDCO) has a P/E ratio of 16.29x, which is below the benchmark median of 45.1x, a difference of -63.88%. P/E is a valuation multiple and is not, by itself, a buy or sell signal.

Indraprastha Medical Corporation Ltd. (INDRAMEDCO) has a ROE of 27.47%, which is above the benchmark median of 12.95%, a difference of +112.12%. Indraprastha Medical Corporation Ltd. (INDRAMEDCO) has a ROCE of 37.7%, which is above the benchmark median of 15.83%, a difference of +138.16%.

Track stocks falling to yearly lows through the Univest 52-week-low screener. The peer table below provides the company-level comparison.

Peer Comparison

Company Symbol Market Cap (Cr) P/E P/B ROE (%) ROCE (%)
KMC Speciality Hospitals (India) Ltd. KMCSHIL 2,761.84 49.52 12.17 24.94 27.25
Dr Agarwals Eye Hospital Ltd. DRAGARWQ 2,504.42 32.86 6.77 25.22 29.21
SURAKSHA DIAGNOSTIC LIMITED SURAKSHA 1,824.13 48.16 6.72 13.81 24.97
Krsnaa Diagnostics Ltd. KRSNAA 1,798.4 18.61 1.83 10.97 13.08
Artemis Medicare Services Ltd. ARTEMISMED 5,326.21 45.1 5.71 12.72 15.83

Indraprastha Medical Corporation Ltd. (INDRAMEDCO) has a P/E ratio of 16.29x compared with the displayed peer median of 45.1x. The comparison is relative and should not be read as a recommendation. Its ROE of 27.47% compares with a peer median of 13.81% across the companies shown in the table. ROCE stood at 37.7% versus the displayed peer median of 24.97%, providing a capital-efficiency comparison. Indraprastha Medical Corporation Ltd. (INDRAMEDCO) has a market capitalisation of Rs 3,062.79 crore. Among the 5 peers shown, only 1 has a larger market capitalisation.

Why Investors Are Watching

  • The Indraprastha Medical Corporation Ltd. 52 Week Low Streak has now run for two straight sessions, so the pattern itself is the first thing to track.
  • The cumulative decline of 2.86% across the streak gives a clearer read than the latest session alone.
  • The latest low of Rs 327.45 is now the reference point for the next close and the next session’s behaviour.
  • The stock’s P/E of 16.29 and P/B of 3.85 show how the streak has changed the pricing of the same earnings and book-value base.
  • The company’s ROE and ROCE remain well above the industry medians, so the Indraprastha Medical Corporation Ltd. 52 Week Low Streak is not the same thing as a deterioration in those ratios.

About the Company

Indraprastha Medical Corporation Ltd. operates in the Healthcare sector and the Hospital & Healthcare Services industry. For a reader following the Indraprastha Medical Corporation Ltd. 52 Week Low Streak, that business context matters because hospital operators are often analysed through a mix of valuation, profitability and market-cap scale. The current market capitalisation is Rs 3,062.79 crore, which helps place the stock in context without changing the basic streak narrative.

In this case, the business backdrop should be read alongside the price pattern rather than instead of it. The Indraprastha Medical Corporation Ltd. 52 Week Low Streak remains the headline feature, while the company’s profitability ratios and earnings base explain why the market is pricing the stock the way it is today.

Track Indraprastha Medical Corporation Ltd. Share Price on Univest

Use Indraprastha Medical Corporation Ltd. (INDRAMEDCO) live share-price page, Univest 52-week-low screener, Univest market blogs to review live stock data, yearly-low lists and related market analysis.

Readers following the Indraprastha Medical Corporation Ltd. 52 Week Low Streak can continue to monitor the stock’s daily close, the latest yearly low and the cumulative move across the streak on Univest. The key is to watch whether the stock extends the pattern or begins to stabilise above the latest low of Rs 327.45.

For ongoing market tracking, the share price page also helps place the decline, valuation and sector comparison in one view.

Disclaimer: Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Uniresearch Global Pvt. Ltd. (Research Analyst, SEBI Reg. No. INH000013776, a subsidiary of Univest Communication Technologies Private Limited).

Frequently Asked Questions

What does the Indraprastha Medical Corporation Ltd. 52 Week Low Streak mean?

Ans. It means the stock has set a fresh 52-week low on consecutive sessions. In this case, the Indraprastha Medical Corporation Ltd. 52 Week Low Streak has reached a second straight session, with the latest low at Rs 327.45.

How many sessions has the stock been making fresh 52-week lows?

Ans. The latest Univest data shows two consecutive sessions. That is why this is described as the Indraprastha Medical Corporation Ltd. 52 Week Low Streak rather than a one-day low event. The stock moved -1.51% during the session.

What is the latest 52-week low for the stock?

Ans. The latest 52-week low is Rs 327.45. That is also the level used in the Indraprastha Medical Corporation Ltd. 52 Week Low Streak analysis for the latest session. The stock moved -1.51% during the session.

Is a company-specific reason confirmed for the repeated lows?

Ans. No. The latest Univest data confirms the repeated-low pattern, but it does not establish a company-specific cause for the continued decline in the Indraprastha Medical Corporation Ltd. 52 Week Low Streak.

How does the stock compare with the sector median on valuation?

Ans. The stock’s P/E of 16.29 is below the industry median of 45.1, and its P/B of 3.85 is slightly below the industry median of 4.1. That places the Indraprastha Medical Corporation Ltd. 52 Week Low Streak below the typical sector.

What profitability metrics stand out in the data?

Ans. ROE is 27.47% and ROCE is 37.7%, both well above the industry medians shown in the peer snapshot. Those figures are important in assessing the Indraprastha Medical Corporation Ltd. 52 Week Low Streak.

How should investors read the repeated low pattern?

Ans. The best reading is that the stock has remained under pressure across more than one session. The Indraprastha Medical Corporation Ltd. 52 Week Low Streak is a pattern to monitor, not a conclusion about the next move.

What should investors track next?

Ans. They should watch whether the stock closes above Rs 327.45, whether the cumulative decline widens beyond 2.86%, and whether the Indraprastha Medical Corporation Ltd. 52 Week Low Streak extends to another session.



Author: Kunal Singla
Kunal Singla is the Associate Director - Research at Univest, leading quantitative equity research, intraday trading setups, and derivatives strategy. With 4+ years of experience in Indian equity markets, he combines rigorous quantitative methods with classical technical analysis to build high-conviction research frameworks for retail and advisory clients. He holds an MSc from the Indian Institute of Technology (IIT) Delhi — one of India's most selective institutions — and has completed the Certificate in Quantitative Finance (CQF), a globally recognised programme covering derivatives pricing, risk modelling, machine learning for finance, and advanced portfolio theory. This combination places him in a small group of Indian analysts with both deep academic training in quantitative methods and SEBI-recognised research credentials. Kunal holds seven SEBI-recognised NISM certifications spanning research, derivatives, portfolio management, and securities operations: Series-XV (Research Analyst), Series-XXI-A (Portfolio Managers), Series-XVI (Commodity Derivatives), Series-VIII (Equity Derivatives), Series-VII (SORM), Series-V-A (Mutual Fund Distributors), and Series-I (Currency Derivatives). At Univest — India's SEBI-registered research and advisory platform — Kunal leads research inputs for Pro Lite, Pro Super, Pro Gold, and Pro Commodity advisory services, alongside publishing intraday stock picks on Univest Blogs.

Leave a Reply Cancel reply